The largest database of trusted experimental protocols

4 protocols using anti cd3 145 2c11

1

Treg Differentiation and Suppression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise noted, Tregs were cultured in RPMI-1640 medium (plus β-mercaptoethanol) supplemented with 10% fetal bovine serum, 1% L-glutamine, 1% penicillin-streptomycin, 50 ng/ml IL-2 and anti-CD3/CD28 coated Dynabeads (Thermo Fisher) at 1:1 ratio (cells: beads). For glucose challenge experiments, glucose-free RPMI-1640 medium (Thermo Fisher, 1187020) were used. 2-DG was purchased from Sigma (D8375). For in vitro iTreg differentiation, 24-well plates were pre-coated with 40 μg/ml anti-hamster antibody (MP Biomedical). CD4+CD25CD44CD62L+ naive T cells were sorted and cultured for 3 days in IMDM (Sigma-Aldrich) supplemented with 0.25 μg/ml anti-CD3 (145-2C11), 1 μg/ml anti-CD28 (37.51), 2 μg/ml anti-IL-4 (11B11), 2 αg/ml anti-IFN-γ (XMG1.2) and 5 ng/ml TGF-β. For in vitro Treg suppression assay, splenocytes from CD45.1+ mice were labeled with Cell Trace Violet (Thermo Fisher) and cultured with or without various ratio of sorted splenic Tregs from control or Tfamfl/flFoxp3Yfp-Cre mice. Cells were cultured for 3d with soluble 1 μg/ml anti-CD3/CD28. The division of CD45.1+CD4+ T cells were assessed by the dilution of Cell Trace Violet.
+ Open protocol
+ Expand
2

Treg Differentiation and Suppression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise noted, Tregs were cultured in RPMI-1640 medium (plus β-mercaptoethanol) supplemented with 10% fetal bovine serum, 1% L-glutamine, 1% penicillin-streptomycin, 50 ng/ml IL-2 and anti-CD3/CD28 coated Dynabeads (Thermo Fisher) at 1:1 ratio (cells: beads). For glucose challenge experiments, glucose-free RPMI-1640 medium (Thermo Fisher, 1187020) were used. 2-DG was purchased from Sigma (D8375). For in vitro iTreg differentiation, 24-well plates were pre-coated with 40 μg/ml anti-hamster antibody (MP Biomedical). CD4+CD25CD44CD62L+ naive T cells were sorted and cultured for 3 days in IMDM (Sigma-Aldrich) supplemented with 0.25 μg/ml anti-CD3 (145-2C11), 1 μg/ml anti-CD28 (37.51), 2 μg/ml anti-IL-4 (11B11), 2 αg/ml anti-IFN-γ (XMG1.2) and 5 ng/ml TGF-β. For in vitro Treg suppression assay, splenocytes from CD45.1+ mice were labeled with Cell Trace Violet (Thermo Fisher) and cultured with or without various ratio of sorted splenic Tregs from control or Tfamfl/flFoxp3Yfp-Cre mice. Cells were cultured for 3d with soluble 1 μg/ml anti-CD3/CD28. The division of CD45.1+CD4+ T cells were assessed by the dilution of Cell Trace Violet.
+ Open protocol
+ Expand
3

In Vitro Treg Cell Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treg cell induction in vitro was performed by culturing 0.2 × 106 sorted T cells/well in 96 well plates pre-coated with anti-CD3 (145–2C11) (1 μg/mL) using Click’s media (Millipore-Sigma) containing 10% fetal bovine serum (FBS) (Gemini); penicillin-streptomycin, L-glutamine, HEPES, β-mercaptoethanol, sodium pyruvate (all from GIBCO); recombinant mouse IL-2 (200 units/ml), human TGF-β1 (0.25 ng/ml, or as indicated in figure legends of individual figures), and anti-CD28 (37.51) (1.5 μg/mL) (Biolegend).
Th0 cultures were prepared by culturing 0.2 × 106 sorted T cells/well with 0.1 × 106 antigen presenting cells (APCs) in the presence of anti-CD3 (145–2C11) (1 μg/ml) (Biolegend) using Click’s media (Millipore-Sigma) containing 10% FBS (Gemini) and penicillin-streptomycin, L-glutamine, β-mercaptoethanol, HEPES, and sodium pyruvate (all from GIBCO) for 1–3 days. The APCs used in these cultures were isolated from pooled lymph node and spleen cells depleted of T cells (CD4+, CD8+, CD3+) and CD49b+ NK cells using biotinylated antibodies (Biolegend) and magnetic microbead selection (Miltenyi).
+ Open protocol
+ Expand
4

In Vitro Treg Cell Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treg cell induction in vitro was performed by culturing 0.2 × 106 sorted T cells/well in 96 well plates pre-coated with anti-CD3 (145–2C11) (1 μg/mL) using Click’s media (Millipore-Sigma) containing 10% fetal bovine serum (FBS) (Gemini); penicillin-streptomycin, L-glutamine, HEPES, β-mercaptoethanol, sodium pyruvate (all from GIBCO); recombinant mouse IL-2 (200 units/ml), human TGF-β1 (0.25 ng/ml, or as indicated in figure legends of individual figures), and anti-CD28 (37.51) (1.5 μg/mL) (Biolegend).
Th0 cultures were prepared by culturing 0.2 × 106 sorted T cells/well with 0.1 × 106 antigen presenting cells (APCs) in the presence of anti-CD3 (145–2C11) (1 μg/ml) (Biolegend) using Click’s media (Millipore-Sigma) containing 10% FBS (Gemini) and penicillin-streptomycin, L-glutamine, β-mercaptoethanol, HEPES, and sodium pyruvate (all from GIBCO) for 1–3 days. The APCs used in these cultures were isolated from pooled lymph node and spleen cells depleted of T cells (CD4+, CD8+, CD3+) and CD49b+ NK cells using biotinylated antibodies (Biolegend) and magnetic microbead selection (Miltenyi).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!